Jazz Pharmaceuticals JAZZ Other intangible assets—net
Other intangible assets—net at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's other intangible assets—net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's other intangible assets—net?
- Jazz Pharmaceuticals (JAZZ) reported other intangible assets—net of $4.2B in Q1 2026.
- How has Jazz Pharmaceuticals's other intangible assets—net changed year-over-year?
- Jazz Pharmaceuticals's other intangible assets—net decreased by 10.9% year-over-year, from $4.72B to $4.2B.
- What is the long-term trend for Jazz Pharmaceuticals's other intangible assets—net?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's other intangible assets—net has grown at a 15.1% compound annual growth rate (CAGR), from $2.2B to $4.43B.